Bendamustine Hydrochloride 16729-0250-03

Package NDC

16729-0250-03

Manufacturer: Accord Healthcare, Inc.
Dosage Form: Injection, Powder, Lyophilized, For Solution
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: December 7, 2022
Listing Expires: December 31, 2026
Application: ANDA205574

Need to source Bendamustine Hydrochloride? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Bendamustine Hydrochloride	25 mg/5mL

Drug Class

Alkylating Activity [MoA]Alkylating Drug [EPC]

Selected Package

16729-0250-03Selected

1 VIAL, SINGLE-DOSE in 1 CARTON (16729-250-03) / 5 mL in 1 VIAL, SINGLE-DOSE